Stendra is the first entrant to the ED space as a second generation
molecule, with an intentionally designed affinity and unprecedented
selectivity for targeted penile target tissue. We believe that Stendra disrupts men’s health and seeks to expand on the diagnosis and treatment of erectile dysfunction as the epicenter of cardiovascular, hormonal, metabolic and psychiatric well-being.
Through our partnership with key clinical opinion leaders and multi-specialty trade associations, as well as outcomes-based data modeling research, Stendra competes for ground beyond lifestyle designation. Stendra is positioned as an opportunity for men and their partners to re-engage in intimacy, on their terms, with an empowered sense of personalization that aims to transcend into overall well-being and healthy living.